A cannabis executive is calling for law enforcement agencies to be better educated on medical
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an
Scientists have developed a new compound to harnesses the pain-relieving properties of cannabis without any
Yep, you can hit the road with your prescribed medical cannabis – but there are a few golden rules: • You must not be impaired (no zombie-mode driving). • Your prescription comes from a specialist consultant (not your mate Dave). • You can prove it (because “trust me, bro” won’t cut it). The DVLA says doctors should clue […]
The post Driving on Medical Cannabis UK: Can You? appeared first on I Am Billy.
Europe’s largest cannabis trade show and fair, Spannabis, has announced that its March 2025 event
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect
The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility has opened its doors to doctors,
Since the legalisation of medical cannabis in the UK in 2018, its integration into mainstream
Written by: Releaf’s Clinical Dr Alex Van Heerden After years prescribing opioids, Dr Alexander Van
Researchers from Brazil have published a detailed study showing significant improvements in a patient living
A recent YouGov poll, asking the British public their views on cannabis reform compared to
At PatientsCann UK, we are deeply concerned by Network Rail’s recently issued safety advice (NRA24-13), which imposes a blanket ban
The post Network Rail’s Medical Cannabis Policy: A Cause for Concern first appeared on PatientsCann UK.
Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD
The legal dispensing of cannabis via a cultivation association has taken place for the first
Six years on from the legalisation of medical cannabis in the UK, families have made
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re
A study has found that a single high dose of psilocybin can lead to physical
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the
The number of items prescribed in the UK’s private medical cannabis market has doubled each
Product Earth, the UK’s largest event celebrating cannabis and other natural medicines, has cancelled the
A new study by researchers in the US is the first to shed light on how HHC binds to receptors in the body – and proposes a safer, more consistent way to produce them. The new paper takes a closer look at hexahydrocannabinol, or HHC, an
The Connecticut Department of Consumer Protection approved nine licenses for dispensaries to commence adult use sales on Tuesday, January 10. While nine were approved, just seven began adult use sales today. Connecticut also launched its “Clean Slate & Cannabis Erasure” website, as the state’s Clean Slate
https://www.protectourpatients.co.uk/ In the realm of medical cannabis, a significant disparity exists between patients’ needs and their access to appropriate treatments. While progress has been made, with the UK government allowing specialists to prescribe cannabis medicines in 2018, a critical challenge remains: general practitioners (GPs) are still unable to prescribe this potentially life-changing therapy. As a consequence, a staggering 1.8 million individuals in the UK are compelled to turn to the illicit cannabis market for medical reasons. This is further exacerbated by the financial strain faced by those on low incomes, who struggle to afford private prescriptions. It’s high time we address these issues and embark on a transformative journey to protect our patients and enhance healthcare outcomes. The ‘Protect our Patients’ campaign is a groundbreaking initiative aimed at rectifying the inequity surrounding medical cannabis prescriptions. Its core mission is to advocate for GPs to be granted the same prescribing rights as consultants, thus empowering them to effectively support their patients in need. By removing the existing barriers, we can ensure that every individual, regardless of their socioeconomic background, has access to safe and effective cannabis-based treatments. In 2018, the UK government acknowledged the therapeutic potential of cannabis medicines and legalised their prescription. However, this progressive step fell short in one crucial aspect: GPs were excluded from the regulatory framework, limiting their ability to provide comprehensive care to their patients. This oversight has resulted in a significant gap in access to medical cannabis, forcing patients to navigate the illicit market or face financial hardship to obtain private prescriptions. GPs serve as the first point of contact for patients, entrusted with their comprehensive healthcare. By granting them the authority to prescribe cannabis medicines, we open doors to a range of benefits: The time has come to bridge the gap in patient care and advocate for the empowerment of GPs to prescribe medical cannabis. Together, let’s protect our patients and ensure equitable access to life-changing treatments. Visit ProtectOurPatients.co.uk to learn more about the campaign, get involved, and be part
The post Empowering GPs to ‘Protect our Patients’: Join the Campaign! first appeared on PatientsCann UK.
The European Medicines Agency (EMA) is looking for scientific research to help it establish guidance on the medicinal use of cannabis flower. The EMA’s Committee on Herbal Medicinal Products (HMPC) is inviting industry, healthcare professionals, patients and government institutions from EU member states, to submit scientific
As Black Friday approaches, The C-Word cannabis marketing experts explain how the holiday could affect canna-retailers. We felt it was a good opportunity to explore the value of this seasonal shopping extravaganza from a retail perspective. In this article, we will take a look at what
Cannabis retail is becoming more and more commonplace in the United States. According to a consumer trends survey by North Hollywood-based cannabis brand Ganja Goddess Inc., 90% of respondents said they used online ordering and delivery services to purchase cannabis. Around 60% reported that online ordering
A study conducted by the US Government has found that 80% of Americans who use cannabis report combustion as their primary method of consumption. The second most common route of consumption reported was ingesting cannabis via edibles or oils, and nearly half of those surveyed claimed
Volteface and The Medical Cannabis Clinicians Society (MCCS) have today been appointed as the new secretariat for the UK’s medical cannabis All-Party Parliamentary Group (APPG). APPGs are informal cross-party groups that have no official status within Parliament, but seek to unite groups of MPs and peers
Ending cannabis prohibition is a topic currently being debated in many countries across the world, Thailand and Malta are two countries that have recently legalised the plant, and many others are putting similar plans into place. During these discussions, the issue of driving under the influence
The final draft of Germany’s cannabis legalisation bill was agreed upon yesterday after negotiations took place between members of the coalition government, paving the way for Germans to be allowed to use cannabis for recreational purposes in the Spring of 2024. Amendments to the bill were
Data taken from the UK Medical Cannabis Registry has shown a positive association between cannabis and improved health-related quality of life for people who have been diagnosed with inflammatory bowel disease (IBD). IBD is an umbrella term for conditions that affect the stomach. Symptoms can range
Ecstasy pills with higher than average levels of MDMA are currently being sold in the UK, according to drug-testing charity The Loop. The warning, issued just before the start of Glastonbury Festival and the summer party season, aims to educate festivalgoers and other drug consumers about
Two hundred Irish TDs received a letter outlining the reasons for cannabis legalisation and a roll-up in the post sparking an investigation The cannabis was sent by An Póst by leading cannabis activists to mark National Legalise Cannabis Day in Ireland. The cannabis was accompanied by
As medical cannabis products have gained increasing attention throughout the world, and particularly in the UK, perhaps one of the most discussed areas of research is that of the potential of cannabinoids in Epilepsy treatments. In 2018, the government rescheduled cannabis following in response to evidence
As the demand for legal cannabis continues to rise and more states come online, it is imperative to enact more rigorous and comprehensive testing solutions to protect the health of consumers. People use cannabis products for wellness and to find relief; they should not be susceptible
New research suggests cannabis may go some way to reducing the risk of developing Type 2 diabetes, while other studies shed light on its potential in fibromyalgia, autism and skin disorders. A wealth of cannabis-related research has been published over the last few months, including studies
Three years since the legalisation of medical cannabis in the UK, Alex Fraser, patient access lead for Grow Pharma, reflects on how far we’ve come and what the future holds. Three years ago the UK government rescheduled unlicensed cannabis medicines from schedule one to two. This
Hangovers are one of the aftereffects often experienced with spirits. Who doesn’t love a good martini or a refreshing margarita? One company is on a mission bring the flavor profile and buzz of spirited drinks without the negative consequences. MXXN is a California-based cannabis infused beverage
Chronic pain affects millions of people in the UK. As the conversation around medical cannabis evolves, many patients and GPs are beginning to explore whether medical cannabis could offer an alternative. In this instalment of our medical cannabis education series, Dr Elisabeth Philipps is joined by
Six years ago today, the UK took a step forward, allowing eligible patients to access medical cannabis for chronic physical and mental health conditions. This November, we celebrate the anniversary of this landmark decision and reflect on the journey so far. Tens of thousands of patients
At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions – such as chronic pain, post-traumatic stress disorder (PTSD) and anxiety. We also have a growing number of patients suffering from these conditions who are military veterans. With a special nod to
Dravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical treatment. It is estimated that one in 15,700 children will be diagnosed with the condition, most of which will experience seizures in their first year of life. The
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re committed to providing the highest standard of medical cannabis care, guided by science. As such, we are concerned about the growing number of people buying cannabis from illegal sources, including online
Medical cannabis has been available for prescription in the UK since November 2018, and since then an ever-growing number of patients have been able to access these medicines. Now, the UK has approved three vaporisers for the medical use of cannabis, offering specialists doctors the ability
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
